TLET H

Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg

Description

Early use of telmisartan/HCTZ dual combinations may be a suitable approach for difficult-to-treat patients with moderate to severe hypertension. The pooled data indicate that antihypertensive treatment using combinations of telmisartan/HCTZ, particularly high-dose T80/H25, is effective and well tolerated in patients older than 65 years as well as in younger patients. This finding, combined with the pharmacokinetic advantages of telmisartan, suggests that telmisartan/HCTZ may be a beneficial combination for older hypertensive patients who may have added CV risk factors and who are generally difficult to treat to goal.

AZILET GROUP

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb

FUZIMOX GROUP

  • product-thumb
  • product-thumb

ADP GROUP

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb

LOTAK GROUP

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb

TLET GROUP

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb

CEPAL GROUP

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb

NSAID

  • product-thumb

CHOLIV GROUP

  • product-thumb
  • product-thumb
  • product-thumb

PANTAL GROUP

  • product-thumb
  • product-thumb

SFT GROUP

  • product-thumb
  • product-thumb
  • product-thumb

URSOLET GROUP

  • product-thumb
  • product-thumb

NEUTRIZYME-P

  • product-thumb

FTWO GROUP

  • product-thumb
  • product-thumb

ATROLET GROUP

  • product-thumb
  • product-thumb
  • product-thumb

SIXAVIT GROUP

  • product-thumb
  • product-thumb

ANTIALLERGIC

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb

VENTEX GROUP

  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb
  • product-thumb